SCHEMBL5358330

SCHEMBL5358330

COc1cc(C)cc(O)c1C=C1C(=O)Nc2ccc(I)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.52
▸ RAF1 P04049 3/20 0.52
▸ MAP1LC3B Q9GZQ8 2/20 0.52
▸ GMNN O75496 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ TP53 P04637 2/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ CYP3A4 P08684 2/20 0.52
▸ CYP2C9 P11712 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ BLM P54132 2/20 0.52
▸ PMP22 Q01453 2/20 0.52
▸ HIF1A Q16665 2/20 0.52
▸ TDP1 Q9NUW8 2/20 0.52
▸ PLK4 O00444 2/20 0.52
▸ PLK1 P53350 2/20 0.52
▸ EGFR P00533 1/20 0.52
▸ NTRK1 P04629 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6687938 0.83 CSNK1D (0.71) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL5366431 0.82 RAF1 (0.61) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL5363455 0.82 MAPT (0.58) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL5361494 0.82 SYK (0.53) MAPTGMNNLMNATP53CYP1A2
SCHEMBL5369940 0.82 CSNK1D (0.46) MAPTGMNNLMNATP53CYP1A2
SCHEMBL7132945 0.81 MAPT (0.59) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL5361291 0.80 MAPT (0.61) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL5368841 0.78 CSNK1D (0.43) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL7136165 0.77 MAPT (0.60) MAPTRAF1MAP1LC3BGMNNLMNA
SCHEMBL7136252 0.76 NPC1 (0.72) MAPTRAF1MAP1LC3BGMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 — — US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MAPT 3048/4885RAF1 245/4885MAP1LC3B 1427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback